Ischemic maculopathy in zidovudine-induced anemia in an HIV-positive man
Kathir Yoganathan1, Michael Austin21Department of Genito-Urinary Medicine, 2Department of Ophthalmology, Singleton Hospital, Sketty, Swansea, SA2 8QA, UKAbstract: Opportunistic cytomegalovirus (CMV) infection is common in severely immunocompromised HIV-positive patients. The retina is the commonest...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/303655579d3c49ba9eaeb9f81d53db5d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Kathir Yoganathan1, Michael Austin21Department of Genito-Urinary Medicine, 2Department of Ophthalmology, Singleton Hospital, Sketty, Swansea, SA2 8QA, UKAbstract: Opportunistic cytomegalovirus (CMV) infection is common in severely immunocompromised HIV-positive patients. The retina is the commonest site of involvement with hemorrhages a prominent feature. CMV retinitis affects 40% of HIV positive patients who have CD4 count of less than 100 cell/mm3, and in these circumstances clinicians are likely to consider commencing anti-CMV therapy without considering other causes. We report a man with HIV who developed bilateral retinal hemorrhages and ischemic maculopathy in association with zidovudine (AZT)-induced anemia. Retinal hemorrhages resolved following blood transfusion.Keywords: Ischemic maculopathy, retinal hemorrhages, anemia, zidovudine, HIV |
|---|